Table 5.
Characteristics of Participants at Inclusion According to the Outcomes of the Novel Algorithm
| False Negative (n = 30) | False Positive (n = 25) | True Negative (n = 346) | True Positive (n = 114) | |
|---|---|---|---|---|
| Age, median (IQR), years | 32 (26–34) | 32 (30–34) | 29.5 (26–33) | 27 (23–30) |
| Weeks of amenorrhea at inclusion, median (IQR) | 25.5 (19–30) | 28 (18–35) | 26 (20–34) | 25 (18 – 32) |
| Known HBV status, n (%) | 10 (33.3) | 12 (48) | 168 (48.5) | 47 (41.2) |
| Prior HBV treatment, n (%) | 0 (0) | 1 (4) | 11 (3.2) | 10 (8.8) |
| Positive HBeAg, n (%) | 0 (0) | 3 (12) | 0 (0) | 89 (78.1) |
| ALT at inclusion, U/L, median (IQR) | 23 (18–27) | 44 (42–52) | 17 (14–23) | 28 (21–46) |
| ALT ≥40 IU/L at inclusion, n (%) | 0 (0) | 22 (88) | 0 (0) | 40 (35) |
| HBV DNA at inclusion, median (IQR) | 6.5 (6–7.3) | 2.8 (1.9–3.1) | 2.3 (1.95–3) | 7.95 (7.5–8.3) |
| HBV DNA >7.3 log10 IU/mL, n (%) | 7 (23.3) | 0 (0) | 0 (0) | 89 (78.1) |
Abbreviations: ALT, alanine aminotransferase; HBeAg, hepatitis B e antigen; HBV, hepatitis B virus; IQR, interquartile range.